
Dr. Eric Leire is the Founder and CEO of Genflow Biosciences, a longevity gene therapy company listed on the London Stock Exchange. An MD and MBA (HEC/Kellogg), he combines research experience from the Harvard AIDS Institute with executive leadership at Pfizer and Biofund Venture Capital. Dr. Leire has guided multiple biotech companies to public listings (Nasdaq) and holds several pharmaceutical patents.